# Rocuronium Bromide Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current - FDA package records: 26 - Latest FDA row update: 08/20/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Baxter Healthcare — Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) — FDA availability: Available — updated: 08/17/2026 - Baxter Healthcare — Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) — FDA availability: Available — updated: 08/17/2026 - Eugia US LLC — Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05) — FDA availability: Available — updated: 08/06/2026 - Fresenius Kabi USA, LLC — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10) — FDA availability: Available — updated: 08/04/2026 - Hikma Pharmaceuticals USA, Inc. — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10) — FDA availability: Available — updated: 08/13/2026 - Hospira, Inc., a Pfizer Company — Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) — FDA availability: Available — updated: 08/07/2026 - Meitheal Pharmaceuticals, Inc. — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06) — FDA availability: Available — updated: 06/01/2026 - Meitheal Pharmaceuticals, Inc. — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11) — FDA availability: Available — updated: 06/01/2026 - Mylan Institutional, a Viatris Company — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) — FDA availability: Available — updated: 08/20/2026 - Mylan Institutional, a Viatris Company — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) — FDA availability: Available — updated: 08/20/2026 - Piramal Critical Care Inc. — Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41) — FDA availability: Limited Availability — updated: 08/04/2026 - Piramal Critical Care Inc. — Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41) — FDA availability: Limited Availability — updated: 08/04/2026 - Sagent Pharmaceuticals — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) — FDA availability: Available — updated: 08/18/2026 - Sandoz Inc. — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92) — FDA availability: Available — updated: 08/18/2026 - Sandoz Inc. — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) — FDA availability: Available — updated: 08/18/2026 - XGen Pharmaceuticals DJB, Inc. — Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) — FDA availability: Available — updated: 08/17/2026 - XGen Pharmaceuticals DJB, Inc. — Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) — FDA availability: Available — updated: 08/17/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/rocuronium-bromide-injection) - [JSON record](https://citefacts.com/shortages/rocuronium-bromide-injection.json)